photo of

Details

Role Biostatistician (Snr Research Officer)
Research area Population Health
Marnie joined the Clinical Epidemiology and Biostatistics Unit (CEBU) as a postdoctoral biostatistician in 2020 after completing her PhD in Biostatistics at the University of Melbourne. Marnie supports a number of research streams at MCRI including COVID Wellbeing and Changing Children's Chances where she provides input on epidemiological design and statistical methods to single- and multi-cohort research projects. Her expertise is underpinned by methodological research in causal inference, conducted as part of the causal team within CEBU.

Marnie has previous experience working at the University of Melbourne Statistical Consulting Centre (2005-2010) and the Centre for Biostatistics and Clinical Trials at Peter MacCallum Cancer Centre (2010-2014).
Marnie joined the Clinical Epidemiology and Biostatistics Unit (CEBU) as a postdoctoral biostatistician in 2020 after completing her PhD in Biostatistics at the University of Melbourne. Marnie supports a number of research streams at MCRI including...
Marnie joined the Clinical Epidemiology and Biostatistics Unit (CEBU) as a postdoctoral biostatistician in 2020 after completing her PhD in Biostatistics at the University of Melbourne. Marnie supports a number of research streams at MCRI including COVID Wellbeing and Changing Children's Chances where she provides input on epidemiological design and statistical methods to single- and multi-cohort research projects. Her expertise is underpinned by methodological research in causal inference, conducted as part of the causal team within CEBU.

Marnie has previous experience working at the University of Melbourne Statistical Consulting Centre (2005-2010) and the Centre for Biostatistics and Clinical Trials at Peter MacCallum Cancer Centre (2010-2014).

Top Publications

  • Dixon, B, Santamaria, JD, Reid, D, Collins, M, Rechnitzer, T, Newcomb, AE, Nixon, I, Yii, M, Rosalion, A, Campbell, DJ. The association of blood transfusion with mortality after cardiac surgery: cause or confounding? (CME). Transfusion 53(1) : 19 -27 2013
    view publication
  • Nguyen, BT, Deb, S, Fox, S, Hill, P, Collins, M, Chua, BH. A Prospective Pathologic Study to Define the Clinical Target Volume for Partial Breast Radiation Therapy in Women With Early Breast Cancer. International Journal of Radiation Oncology • Biology • Physics 84(5) : 1116 -1122 2012
    view publication
  • Iland, HJ, Bradstock, K, Supple, SG, Catalano, A, Collins, M, Hertzberg, M, Browett, P, Grigg, A, Firkin, F, Hugman, A, et al. All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4). Blood 120(8) : 1570 -1580 2012
    view publication
  • Lim, AM, Young, RJ, Collins, M, Fox, SB, McArthur, GA, Corry, J, Peters, L, Rischin, D, Solomon, B. Correlation of Ataxia-Telangiectasia-Mutated (ATM) gene loss with outcome in head and neck squamous cell carcinoma. Oral Oncology 48(8) : 698 -702 2012
    view publication
  • Collins, IM, Kelleher, F, Stuart, C, Collins, M, Kennedy, J. Clinical Decision Aids in Colon Cancer: A Comparison of Two Predictive Nomograms. Clinical Colorectal Cancer 11(2) : 138 -142 2012
    view publication

Page 12 of 15